Dermatopharmacokinetic Trial of LEO 90100 Foam

Trial Profile

Dermatopharmacokinetic Trial of LEO 90100 Foam

Phase of Trial: Phase I

Latest Information Update: 28 May 2018

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone-dipropionate/calcipotriol
  • Indications Plaque psoriasis; Psoriasis
  • Focus Pharmacokinetics
  • Sponsors LEO Pharma
  • Most Recent Events

    • 17 May 2018 Status changed from not yet recruiting to recruiting.
    • 29 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top